United Therapeutics Stock (NASDAQ: UTHR) stock price, news, charts, stock research, profile.
Open | $261.410 |
Close | $266.220 |
Volume / Avg. | 686.557K / 513.658K |
Day Range | 260.930 - 266.650 |
52 Wk Range | 204.440 - 264.850 |
Market Cap | $11.811B |
P/E Ratio | 12.335 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 12.85% |
Days to Cover | 9 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of United Therapeutics (NASDAQ: UTHR) through any online brokerage.
Other companies in United Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for United Therapeutics (NASDAQ: UTHR) was reported by Goldman Sachs on Friday, May 3, 2024. The analyst firm set a price target for 240.00 expecting UTHR to fall to within 12 months (a possible -9.85% downside). 15 analyst firms have reported ratings in the last year.
The stock price for United Therapeutics (NASDAQ: UTHR) is $266.22 last updated May 7, 2024 at 5:54 PM EDT.
There are no upcoming dividends for United Therapeutics.
United Therapeutics’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
There is no upcoming split for United Therapeutics.
United Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.